Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIP: FX006 in Shoulder and Hip OA
NCT03382262Phase 2Completed
- Sponsor
- Pacira BioSciences
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in osteoarthritis (OA), sponsored by Pacira BioSciences. Started Dec 2017; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03382262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03382262.